2 min read
Meeting Early Phase Study Challenges – a Data Management Perspective
First-in-Human studies are a discovery point, which can decide the fate of a compound as well as lay the groundwork for subsequent phases of a...
2 min read
How COVID Changed the Diagnostic Industry – for Better
It goes without saying that the pandemic has disrupted all aspects of our lives especially the healthcare system, including the diagnostic industry....
2 min read
Medical Writing in Early Phase Studies
Is specialized knowledge needed for Medical Writers working on early phase studies? Based on the characteristics and needs of Phase 1, 1a, 1b, BA-BE...
2 min read
Three Key Points to Prepare for an Early Phase Clinical Trial
Companies preparing for an early phase study must deal with an array of challenges and decisions for biometrics, pharmacovigilance and regulatory...
3 min read
Plan to Mitigate Challenges in Pharmacovigilance and Drug Safety
Biopharmaceutical companies worldwide are developing better and most cost-effective medicines at an unprecedented rate. With billions of dollars...
2 min read
China Reveals Its 2025 Coverage Goals for Publicly Funded Healthcare
In September 2021, China’s National Healthcare Security Administration (NHSA), the government agent in charge of publicly funded healthcare announced...
2 min read
Provider and Patient Preference Studies: Demonstrating Product Demand for Drugs, Medical Devices, and Diagnostics
Pharmaceutical manufacturers, medical device companies, and advanced diagnostic manufacturers are increasingly incorporating patients’ and providers’...
1 min read
China Aims to Complete Transition to DRG Payment Model for Inpatient Care by 2024
In November 2021, the Chinese government announced its 3-year (2022-2024) payment reform plan with the end goal to fully implement a diagnosis...
1 min read
Consumable vs. Instrument, the Creative Tension in Diagnostics Technology
By Juan F. Roman